Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals's GHG Emissions Data Preview
In 2025, Alembic Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Alembic Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Alembic Pharmaceuticals's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of Alembic Pharmaceuticals amounted to 158,244.01 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Alembic Pharmaceuticals increased by 14.11%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Alembic Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Alembic Pharmaceuticals's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Alembic Pharmaceuticals were 80,278.03 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2024), Alembic Pharmaceuticals's Scope 1 emissions increased by 12.86%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Alembic Pharmaceuticals's Scope 2 emissions?
In 2025, Alembic Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 77,965.98 tCOâ‚‚e without specifying the calculation method.
Has Alembic Pharmaceuticals reduced its Scope 2 emissions over time?
Compared to the previous year (2024), Alembic Pharmaceuticals's Scope 2 emissions (Unspecified Calculation Method) rose by 15.43% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Alembic Pharmaceuticals use for Scope 2 reporting?
In 2025, Alembic Pharmaceuticals reported its Scope 2 emissions using an unspecified methodology.
Alembic Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)